Imitrex Injection
Product Images NDC 0173-0739

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Imitrex (NDC 0173-0739). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sumatriptan Chemical Structure (Imitrex Inj Spl Graphic 01)

Chemical structure diagram of sumatriptan, the active ingredient in IMITREX injection by GlaxoSmithKline LLC, showing its molecular components and a co-crystallized molecule.*

FDA Label Image

Imitrex Inj Graph Time To Relief V3-01 (Imitrex Inj Spl Graphic 02)

A line graph comparing the estimated percentage of patients with relief over time (in minutes) for IMITREX injection versus placebo. The x-axis represents time from 0 to 25 minutes, and the y-axis shows the percentage of patients with relief from 0% to 100%. IMITREX data points are shown with circles, placebo with squares, illustrating higher relief percentages for IMITREX across all time points.*

FDA Label Image

Statdose System (Imitrex Inj Spl Graphic 03)

Packaging of IMITREX sumatriptan injection showing two rectangular devices with rounded corners, one with a blue circle and the other with a yellow circle. The devices likely represent different strengths or dosage options, consistent with the 4 mg/0.5 mL and 6 mg/0.5 mL subcutaneous injection forms by GlaxoSmithKline LLC.*

FDA Label Image

Carrying Case (Imitrex Inj Spl Graphic 04)

An instructional illustration showing the components of the IMITREX STATdose Pen system for subcutaneous injection. It includes a carrying case, a cartridge pack containing syringe cartridges, and the IMITREX STATdose Pen featuring a blue button and safety catch.*

FDA Label Image

Figure A (Imitrex Inj Spl Graphic 05)

An instructional diagram showing how to insert a sumatriptan injection cartridge into the IMITREX injection device. Hands demonstrate removing the cartridge from packaging and placing it into the device, which has a protective tamper-evident seal indicated on the cartridge top under the cap.*

FDA Label Image

Figure B (Imitrex Inj Spl Graphic 06)

An instructional image demonstrating the use of an autoinjector device for IMITREX (sumatriptan) injection. It depicts a hand removing the autoinjector from its case and highlights the proper orientation of its blue cap, indicating the priming rod location with a warning not to remove or pull the priming rod.*

FDA Label Image

Figure C (Imitrex Inj Spl Graphic 07)

Instructional illustration showing the use of an IMITREX (sumatriptan) subcutaneous injection device. The image depicts hands rotating the injector cartridge inside the device, demonstrating how to prepare the injection for use.*

FDA Label Image

Figure D (Imitrex Inj Spl Graphic 08)

An instructional illustration showing a hand inserting a syringe cartridge into a white and blue injection device, with a label pointing to the syringe cartridge. This image relates to the use of IMITREX (sumatriptan) injectable product for subcutaneous administration.*

FDA Label Image

Figure E (Imitrex Inj Spl Graphic 09)

Illustration showing a person preparing to self-administer a subcutaneous injection with a pen device, demonstrating use on the outer arm. The image highlights the injection technique relevant to subcutaneous dosage forms such as IMITREX (sumatriptan) injection by GlaxoSmithKline LLC.*

FDA Label Image

Figure F (Imitrex Inj Spl Graphic 10)

An instructional illustration showing the subcutaneous injection of IMITREX (sumatriptan) using an autoinjector. The main image depicts a person administering the injection to the outer thigh, with two inset images demonstrating how to correctly position and hold the autoinjector before and after use.*

FDA Label Image

Figure G (Imitrex Inj Spl Graphic 11)

A person is shown administering a subcutaneous injection to the outer thigh using a prefilled injection device. The image illustrates the method of self-injection for a drug in injection form, specifically highlighting the proper placement on the thigh.*

FDA Label Image

Figure H (Imitrex Inj Spl Graphic 12)

Photograph showing a person holding an IMITREX subcutaneous injection pen with a blue needle cap, demonstrating the product's use as a subcutaneous injection device for sumatriptan, a prescription drug by GlaxoSmithKline LLC.*

FDA Label Image

Figure I (Imitrex Inj Spl Graphic 13)

An illustration showing a person's hands handling an auto-injector device, likely for subcutaneous injection. The device is white and blue with a button, being inserted into a protective holder with a hinged lid. This setup is consistent with an injection delivery system such as for sumatriptan (IMITREX) subcutaneous injection.*

FDA Label Image

Figure J (Imitrex Inj Spl Graphic 14)

An instructional illustration showing hands holding and rotating an IMITREX (sumatriptan) injection device, specifically a subcutaneous autoinjector. The image demonstrates the proper rotation action needed to prepare the device for injection.*

FDA Label Image

Figure K (Imitrex Inj Spl Graphic 15)

An instructional illustration showing hands preparing an IMITREX (sumatriptan) injection device for subcutaneous use. The image depicts a person holding the injection pen above an open carrying case containing the medicine cartridge and related components, demonstrating the setup process for the IMITREX injection.*

FDA Label Image

Figure L (Imitrex Inj Spl Graphic 16)

An instructional illustration showing a person holding and preparing a device for subcutaneous injection of IMITREX (sumatriptan). The image demonstrates the device with an open lid and a hand adjusting the injection cartridge, highlighting the use of this human prescription drug injection.*

FDA Label Image

Figure M (Imitrex Inj Spl Graphic 17)

An instructional illustration showing a hand placing an IMITREX (sumatriptan) injection device, labeled with GlaxoSmithKline LLC branding and dosage information, into a white and blue electronic device with a flip-open lid. The device is used for subcutaneous injection of IMITREX.*

FDA Label Image

Figure N (Imitrex Inj Spl Graphic 18)

Illustration showing the IMITREX (sumatriptan) injection device and its protective carrying case. The open case reveals an injector with a visible tamper-evident seal label on top. The device is designed for subcutaneous administration and is part of the product packaging by GlaxoSmithKline LLC.*

FDA Label Image

Figure O (Imitrex Inj Spl Graphic 19)

An instructional illustration showing hands preparing an IMITREX (sumatriptan) injection device for subcutaneous use. The image features a small vial labeled IMITREX being inserted into a compact, handheld injector with a flip-top cap open, demonstrating the setup process.*

FDA Label Image

Figure P (Imitrex Inj Spl Graphic 20)

An instructional illustration showing the use of a subcutaneous injection device for IMITREX (sumatriptan). The device is held with one hand, with the cap opened and a visible button on the front, which is highlighted by an arrow labeled 'BUTTON.' The image demonstrates how to press the button to administer the injection.*

FDA Label Image

Figure Q (Imitrex Inj Spl Graphic 21)

An illustration of a red biohazard sharps disposal container with a white lid and a prominent orange warning label featuring a black biohazard symbol and the word "WARNING." The container is designed for safe disposal of used medical sharps.*

FDA Label Image

Imitrex Injection 4mg Cartridge Label (Imitrex Inj Spl Graphic 22)

IMITREX 4 mg subcutaneous injection label by GlaxoSmithKline LLC features a white background with the product name and active ingredient sumatriptan prominently displayed. The label indicates a 0.5 mL volume per dose and specifies packaging of 2 single-dose syringe cartridges for human prescription use.*

FDA Label Image

Imitrex Injection 6mg Cartridge Label (Imitrex Inj Spl Graphic 23)

IMITREX (sumatriptan) Injection label showing subcutaneous injection dosage form. The label indicates a 6 mg strength in a 0.5 mL volume, packaged as 2 single-dose syringe cartridges. The product is for prescription use only, labeled by GlaxoSmithKline LLC.*

FDA Label Image

Imitrex Injection 6mg Vial Carton (Imitrex Inj Spl Graphic 24)

Packaging label for IMITREX STATdose SYSTEM injection containing sumatriptan. The label indicates the product includes 2 prefilled 0.5 mL syringes each with 6 mg sumatriptan for subcutaneous injection, one IMITREX STATdose pen, a carrying case, instructions for use, patient information, and prescribing information. The labeler is GlaxoSmithKline LLC. Strength shown is 6 mg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.